Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
91.94
-1.76 (-1.87%)
Jan 17, 2025, 4:00 PM EST - Market closed
Axsome Therapeutics Employees
Axsome Therapeutics had 545 employees as of December 31, 2023. The number of employees increased by 162 or 42.30% compared to the previous year.
Employees
545
Change (1Y)
162
Growth (1Y)
42.30%
Revenue / Employee
$621,022
Profits / Employee
-$570,560
Market Cap
4.46B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AXSM News
- 20 days ago - Axsome Therapeutics Remains A Buy Despite AXS-05's Mixed Results - Seeking Alpha
- 20 days ago - Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results - Benzinga
- 21 days ago - Axsome Therapeutics, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 21 days ago - Axsome's drug for Alzheimer's disease agitation meets main goal in late-stage study - Reuters
- 21 days ago - Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer's Disease Agitation - GlobeNewsWire
- 7 weeks ago - Axsome: Focus On AXS-12 Targeting Narcolepsy, Which Just Released Positive Data - Seeking Alpha
- 7 weeks ago - Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says - Benzinga
- 2 months ago - Axsome Therapeutics, Inc. (AXSM) Q3 2024 Earnings Call Transcript - Seeking Alpha